Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Avista Corp. has made available its November 2026 investor presentation detailing its strategic priorities, including a $3.6 billion capital expenditure plan for 2027-2031. The presentation highlights the company's long-term utility earnings growth target of 4-6% and its aspirational goals for 100% clean electricity by 2045.
AST SpaceMobile announced plans to build its own 20-ton rocket to deploy its BlueBird satellites in low-Earth orbit. The company will utilize Miranda engines from Firefly Aerospace for the launch vehicle, representing a major vertical integration of its satellite deployment infrastructure.
CVD Equipment Corporation held its 2026 Annual Meeting of Shareholders on November 5, 2026. Shareholders elected five directors to serve until the 2027 Annual Meeting, ratified CBIZ CPAs P.C. as the independent auditor for fiscal year 2026, and approved a non-binding advisory resolution on executive compensation.
First Breach announced a strategic supply agreement to purchase up to 20 million primers per month and a separate raw material sourcing agreement to support its production ramp. The company also added two ammunition inspection units to its Hagerstown facility as it scales toward a capacity of 20 million rounds per month and transitions to 24-hour operations.
TuHURA Biosciences $50M Debt Financing with Parkview Holdings One LLC
TuHURA Biosciences borrowed an additional $1.5 million under its existing revolving credit facility with Parkview Holdings One LLC. The facility, which matures in April 2031, has a maximum loan availability of $50 million. The company intends to use the proceeds for general corporate purposes.
Stockholders approved an amendment to the Certificate of Incorporation authorizing the Board to effect a reverse stock split at a ratio between 1-for-2 and 1-for-50. The move is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement (Listing Rule 5550(a)(2)).
SI-BONE Chief Op & Financial Officer Anshul Maheshwari Sells $81.2K of Stock
Anshul Maheshwari, Chief Op & Financial Officer, sold 3,247 shares of SI-BONE, Inc. at $25.00 a share, worth $81.2K in total on Nov 4, 2026. Shares held after the trade: 211,250 (-1.5%).
Delta Air Lines President Peter W. Carter Sells $4.01M of Stock
Peter W. Carter, President, sold 44,950 shares of Delta Air Lines, Inc. at $89.29 a share, worth $4.01M in total on Nov 4, 2026. Shares held after the trade: 379,754 (-10.6%).
Cullinan Therapeutics CSO Jennifer Michaelson Sells $49.4K of Stock
Jennifer Michaelson, CSO, sold 4,000 shares of Cullinan Therapeutics, Inc. at $12.36 a share, worth $49.4K in total on Nov 5, 2026. Shares held after the trade: 158,649 (-2.5%).
HEI is streamlining into a pure-play utility, managing wildfire liabilities through prepayments and insurance while awaiting a critical 2027 rate case decision.
For the nine months ended September 30, 2026, the Trust reported a net decrease in net assets from operations of $296 million, primarily driven by a $314.6 million change in unrealized loss on bullion. Despite the operational loss, net assets grew to $2.6 billion due to $382.9 million in share creations, while the net asset value per share decreased from $206.19 to $187.41 during the period.
Appfolio 10% Owner Maurice J. Duca Sells $2.59M of Stock
Maurice J. Duca, 10% Owner, sold 10,800 shares of Appfolio Inc at $240.00 to $240.15 a share (average $240.08) in 6 transactions, worth $2.59M in total between Nov 4, 2026 and Nov 5, 2026. Shares held after the trade: 27,700 (-5.5%).
Establishment Labs Holdings Inc. reported 29,823,470 common shares outstanding as of November 5, 2026. The company's balance sheet shows a stable cash position of $75.8 million as of September 30, 2026, compared to $75.6 million at the end of 2025, while total current assets increased slightly to $255.7 million.
Block Insider Anthony Mathew Eisen Sells $3.06M of Stock
Anthony Mathew Eisen sold 35,000 shares of Block, Inc. at $87.50 a share, worth $3.06M in total on Nov 4, 2026. Shares held after the trade: 1,177,672 (-2.9%).
For the quarter ended September 30, 2026, Medical Properties Trust reported net income of $202.1 million, a significant recovery from a net loss of $77.5 million in the prior year period, primarily driven by a $157.8 million gain on the sale of real estate. Total revenues increased to $250.1 million from $237.5 million, while the company maintained a quarterly dividend of $0.09 per share.
For the nine months ended September 30, 2026, Medical Properties Trust reported net income of $232.9 million, a significant recovery from a net loss of $293.5 million in the prior year period. The improvement was driven by higher billed rent and a substantial gain on the sale of real estate totaling $163.4 million.
Invesco Mortgage Capital Inc. reported a net loss of $80.5 million for the nine months ended September 30, 2026, compared to a net income of $49.8 million in the prior year period. The loss was primarily driven by a $478.2 million net loss on investments, despite a significant increase in net interest income to $91.1 million. Total assets grew to $7.8 billion as of September 30, 2026, up from $6.5 billion at the end of 2025.
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $1.17M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 1,950 shares of United Therapeutics Corp at $593.14 to $602.49 a share (average $597.75) in 8 transactions, worth $1.17M in total on Nov 5, 2026. Shares held after the trade: 324,443 (-0.0%).
Crocs Insider Douglas J. Treff Sells $1.71M of Stock
Douglas J. Treff sold 10,714 shares of Crocs, Inc. at $159.21 a share, worth $1.71M in total on Nov 4, 2026. Shares held after the trade: 61,371 (-14.9%).
Kodiak Sciences Director Baker Bros. Advisors LP Buys $24.3M of Stock
Baker Bros. Advisors LP, Director, bought 247,090 shares of Kodiak Sciences Inc. at $98.51 a share, worth $24.3M in total between Nov 4, 2026 and Nov 5, 2026. Shares held after the trade: 20,424,859 (+0.4%).
For the nine months ended September 30, 2026, the Trust reported a net decrease in net assets from operations of $424.7 million, primarily driven by a $750.9 million unrealized loss on platinum. During the period, the Trust also executed a ten-for-one forward share split on May 14, 2026, and saw its net asset value per share decrease from $18.41 to $15.50.
CPS Technologies reported record quarterly revenue of $8.9 million and a net income of $0.6 million for Q3 2026. The company achieved gross margin expansion to 20.9% and signed a long-term lease for a new 80,000-square-foot facility in Attleboro, Massachusetts to double its production capacity.
Term
Q3 2026
“We are pleased to report solid progress this quarter on a number of fronts. Due to higher demand and increased production, our quarterly revenue rose to a new high and gross margins expanded to 20.9% – a level not seen since during our HybridTech Armor® contracts more than three years ago.”
Brian Mackey, President and CEO
“This proves the resilience of our product lines, interest in our broadening portfolio of offerings, and sound operating execution. We also recently announced the signing of a lease in nearby Attleboro that will allow CPS to further expand operations in support of increased top line growth and higher returns for our shareholders.”
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.33M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 7,540 shares of United Therapeutics Corp at $562.51 to $591.54 a share (average $573.89) in 24 transactions, worth $4.33M in total on Nov 5, 2026. Shares held after the trade: 326,403 (-0.0%).
As of September 30, 2026, the Trust held $637.6 million in palladium, a decrease from $1.0 billion at the end of 2025, primarily driven by significant net redemptions and a $259.5 million unrealized loss. The Trust continues to operate as a grantor trust with a 0.60% annual Sponsor's Fee paid through in-kind palladium transfers.
Cathay General Bancorp reported net income of $95.2 million for the third quarter of 2026, an increase from $77.7 million in the prior year period. Total assets grew to $25.6 billion, driven by a $1.1 billion net increase in loans and a $940.8 million increase in deposits during the first nine months of the year.
Regional Management Director Sandra K. Johnson Sells $104K of Stock
Sandra K. Johnson, Director, sold 2,700 shares of Regional Management Corp. at $38.27 to $39.45 a share (average $38.57) in 2 transactions, worth $104K in total on Nov 5, 2026. Shares held after the trade: 17,873 (-3.7%).
Kiniksa Pharmaceuticals International Chairman & CEO Sanj K. Patel Sells $14.3M of Stock
Sanj K. Patel, Chairman & CEO, sold 151,300 shares of Kiniksa Pharmaceuticals International, plc at $92.35 to $96.05 a share (average $94.71) in 5 transactions, worth $14.3M in total on Nov 4, 2026. Shares held after the trade: 774,500 (-3.4%).
Radian Group Inc. reported its 2026 third-quarter results, highlighting the February 2026 acquisition of Inigo and the subsequent wind-down of its Mortgage Conduit business. The company also announced the sale of its Real Estate Services business in August 2026 and entered a definitive agreement to sell Radian Title Insurance, classifying both as discontinued operations.
Dream Finders Homes Director Len Sturm Buys $10.5K of Stock
Len Sturm, Director, bought 1,000 shares of Dream Finders Homes, Inc. at $10.53 a share, worth $10.5K in total on Nov 4, 2026. Shares held after the trade: 31,728 (+3.3%).
J.P. Morgan Real Estate Income Trust, Inc. reported total revenues of $94.9 million for the nine months ended September 30, 2026, a significant increase from $44.1 million in the prior year period. Despite the revenue growth, the company recorded a net loss attributable to stockholders of $1.3 million for the nine-month period, though it achieved a quarterly net income of $0.4 million in Q3 2026.